Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 6/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL691276 | 1.00 | HCAR2 (0.63) | HCAR2ATMAPPALOX5HPGD | |
| SCHEMBL9561910 | 1.00 | HCAR2 (0.63) | HCAR2ATMAPPALOX5HPGD | |
| SCHEMBL690841 | 0.87 | ATM (0.76) | HCAR2ATMAPPHPGDTSHR | |
| SCHEMBL690840 | 0.87 | ATM (0.76) | HCAR2ATMAPPHPGDTSHR | |
| SCHEMBL9561881 | 0.87 | ATM (0.76) | HCAR2ATMAPPHPGDTSHR | |
| SCHEMBL448456 | 0.85 | HCAR2 (0.82) | HCAR2ATMAPPALOX5HPGD | |
| SCHEMBL322228 | 0.85 | HCAR2 (0.82) | HCAR2ATMAPPALOX5HPGD | |
| SCHEMBL448454 | 0.85 | HCAR2 (0.82) | HCAR2ATMAPPALOX5HPGD | |
| SCHEMBL27672601 | 0.85 | HCAR2 (0.67) | HCAR2ATMAPPHPGDTSHR | |
| SCHEMBL10818991 | 0.84 | HCAR2 (0.61) | HCAR2ATMAPPALOX5HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | claimed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | claimed |
| EP-2205557-B1 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2012-02-29 | — | — | EP | claimed |
| CN-101965330-A | Method for producing beta-mercapto carboxylic acids | SHOWA DENKO KK | 2011-02-02 | — | — | CN | claimed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | claimed |
| US-20110004017-A1 | METHOD FOR PRODUCING B-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-06 | — | — | US | claimed |
| EP-2268614-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2011-01-05 | — | — | EP | claimed |
| CN-101801922-A | Method for producing beta-mercaptocarboxylic acids | SHOWA DENKO KK | 2010-08-11 | — | — | CN | claimed |
| EP-2205557-A2 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2010-07-14 | — | — | EP | claimed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | claimed |
| WO-2009038232-A2 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-03-26 | — | — | WO | claimed |
| EP-0250997-A2 | Valproic and (E)-2-valproenoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions therefrom | CHIESI FARMACEUTICI S.p.A. (IT) | 1988-01-07 | — | — | EP | claimed |
| US-10777850-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| EP-3554275-A1 | MODIFYING OR ENHANCING A FLAVOR OF FOOD AND BEVERAGE PRODUCTS | Tate & Lyle Ingredients Americas LLC (US) | 2019-10-23 | — | — | EP | disclosed |
| CN-106415910-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2019-05-03 | — | — | CN | disclosed |
| US-20190051941-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| EP-0206143-A1 | Process for the preparation of 4-pentenoic-acid esters | BASF Aktiengesellschaft (DE) | 1986-12-30 | — | — | EP | disclosed |
| EP-0126349-B1 | PROCESS FOR THE PREPARATION OF 4-PENTENOIC-ACID ESTERS | BASF Aktiengesellschaft (DE) | 1986-08-20 | — | — | EP | disclosed |
| US-4529815-A | Preparation of 4-pentenoates | BASF AKTIENGESELLSCHAFT (DE) | 1985-07-16 | — | — | US | disclosed |
| EP-0126349-A1 | Process for the preparation of 4-pentenoic-acid esters | BASF Aktiengesellschaft (DE) | 1984-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | CBS, ALDH7A1, CBR1 | HCAR2 174/4885ATM 3847/4885APP 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.